Groundbreaking study uncovers hundreds of genetic markers linked to insulin resistance

A genome-wide study of 402,398 individuals identifies 369 SNPs associated with insulin resistance, offering insights into metabolic diseases and potential therapeutic targets.

EMA asks for more information after safety signal arises for GLP-1s, semaglutide in thyroid cancer

The European Medicines Agency is concerned there could be a potential link between thyroid cancer and the use of glucagon-like peptide-1 (GLP-1) receptor agonists, which

June 23, 2023

Absci and MSK Collaborate on Generative AI Drug Discovery

What You Should Know: – Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center

August 13, 2024

Bulevirtide/Pegylated Interferon Combo Beats Monotherapy for Chronic Hepatitis D

Treatment with the investigational drug bulevirtide plus pegylated interferon alfa-2a (PegIFNα) resulted in more patients achieving undetectable levels of hepatitis D virus (HDV) RNA compared

June 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.